Significant Results and Highly Satisfied Patients
Several clinical studies of HaiRestart® have demonstrated high efficacy and an absence of adverse effects. Significant improvement of hair growth along with increased hair density, and a stabilization of hair loss were reported, regardless of AGA (androgenetic alopecia) grade, patient age or AGA duration.
The results of patients’ blind evaluation in one study (Day D. et al., 2021) indicated improvement in hair quality in 93% of patients, which was not correlated with age or AGA grade. In other studies (Dekeyser B., 2019 and Mercik G. et al., 2021), patients reported subjective feedback as well, describing a more elastic and less dry scalp, and thicker, more durable, healthier and denser hair than previously.